Cargando…
Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702863/ https://www.ncbi.nlm.nih.gov/pubmed/36434204 http://dx.doi.org/10.1038/s41390-022-02360-w |
_version_ | 1784839741322035200 |
---|---|
author | Bode, Lars Bertrand, Kerri Najera, Julia A. Furst, Annalee Honerkamp-Smith, Gordon Shandling, Adam D. Chambers, Christina D. Camerini, David Campo, Joseph J. |
author_facet | Bode, Lars Bertrand, Kerri Najera, Julia A. Furst, Annalee Honerkamp-Smith, Gordon Shandling, Adam D. Chambers, Christina D. Camerini, David Campo, Joseph J. |
author_sort | Bode, Lars |
collection | PubMed |
description | BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the antigenic regions of SARS-CoV-2 proteins that were reactive with antibodies in breast milk. METHODS: Between March 2020 and September 2020, 21 women with confirmed SARS-CoV-2 infection were enrolled in Mommy’s Milk. Participants donated serial breast milk samples around their time of illness. Breast milk samples were used to probe a multi-coronavirus protein microarray containing full-length and variable-length overlapping fragments of SARS-CoV-2 proteins. Samples were also tested against S and N proteins by electrochemiluminescence assay. RESULTS: The breast milk samples contained IgA reactive with a variety of SARS-CoV-2 antigens. The most IgA-reactive SARS-CoV-2 proteins were N (42.9% of women responded to ≥1 N fragment) and S proteins (23.9% responded to ≥1 fragment of S1 or S2). IgG responses were similar. A striking observation was the dissimilarity between mothers in antibody recognition, giving distinct antibody reactivity and kinetic profiles. CONCLUSIONS: Individual COVID-19 cases had diverse and unique milk IgA profiles following the onset of symptoms. IMPACT: In this observational longitudinal case series of 21 women with confirmed SARS-CoV-2 infection, IgA binding to SARS-CoV-2 proteins detected by orthologous proteome microarray and electrochemiluminescence assays was observed in >75% of women, but there was heterogeneity in which antigens and how many were reactive between women. Immunological profiles of protein regions recognized by each woman were distinct. Diverse repertoires of mucosal breast milk antibody to SARS-CoV-2 reflect heterogeneous passive transfer of maternal antibody to exposed breastfeeding infants. |
format | Online Article Text |
id | pubmed-9702863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97028632022-11-28 Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection Bode, Lars Bertrand, Kerri Najera, Julia A. Furst, Annalee Honerkamp-Smith, Gordon Shandling, Adam D. Chambers, Christina D. Camerini, David Campo, Joseph J. Pediatr Res Clinical Research Article BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the antigenic regions of SARS-CoV-2 proteins that were reactive with antibodies in breast milk. METHODS: Between March 2020 and September 2020, 21 women with confirmed SARS-CoV-2 infection were enrolled in Mommy’s Milk. Participants donated serial breast milk samples around their time of illness. Breast milk samples were used to probe a multi-coronavirus protein microarray containing full-length and variable-length overlapping fragments of SARS-CoV-2 proteins. Samples were also tested against S and N proteins by electrochemiluminescence assay. RESULTS: The breast milk samples contained IgA reactive with a variety of SARS-CoV-2 antigens. The most IgA-reactive SARS-CoV-2 proteins were N (42.9% of women responded to ≥1 N fragment) and S proteins (23.9% responded to ≥1 fragment of S1 or S2). IgG responses were similar. A striking observation was the dissimilarity between mothers in antibody recognition, giving distinct antibody reactivity and kinetic profiles. CONCLUSIONS: Individual COVID-19 cases had diverse and unique milk IgA profiles following the onset of symptoms. IMPACT: In this observational longitudinal case series of 21 women with confirmed SARS-CoV-2 infection, IgA binding to SARS-CoV-2 proteins detected by orthologous proteome microarray and electrochemiluminescence assays was observed in >75% of women, but there was heterogeneity in which antigens and how many were reactive between women. Immunological profiles of protein regions recognized by each woman were distinct. Diverse repertoires of mucosal breast milk antibody to SARS-CoV-2 reflect heterogeneous passive transfer of maternal antibody to exposed breastfeeding infants. Nature Publishing Group US 2022-11-25 2023 /pmc/articles/PMC9702863/ /pubmed/36434204 http://dx.doi.org/10.1038/s41390-022-02360-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Research Article Bode, Lars Bertrand, Kerri Najera, Julia A. Furst, Annalee Honerkamp-Smith, Gordon Shandling, Adam D. Chambers, Christina D. Camerini, David Campo, Joseph J. Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title | Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title_full | Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title_fullStr | Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title_full_unstemmed | Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title_short | Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection |
title_sort | characterization of sars-cov-2 antibodies in human milk from 21 women with confirmed covid-19 infection |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702863/ https://www.ncbi.nlm.nih.gov/pubmed/36434204 http://dx.doi.org/10.1038/s41390-022-02360-w |
work_keys_str_mv | AT bodelars characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT bertrandkerri characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT najerajuliaa characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT furstannalee characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT honerkampsmithgordon characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT shandlingadamd characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT chamberschristinad characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT camerinidavid characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection AT campojosephj characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection |